Medical Radiation Detection Market: Key Technologies and Future Growth Drivers
Medical Radiation Detection Market: An Overview
The Medical Radiation Detection Market has been growing steadily as healthcare facilities across the world recognize the importance of radiation detection and monitoring to safeguard patients and healthcare workers from harmful radiation exposure. This blog will provide a comprehensive overview of the medical radiation detection market, highlighting...
Latent Tuberculosis (TB) Testing Market: Current Trends, Challenges, and Future Insights
Tuberculosis (TB) is one of the most persistent and challenging infectious diseases globally. While active TB often receives more attention due to its symptomatic and contagious nature, latent TB infection (LTBI) is a crucial area of concern in public health. In LTBI, individuals are infected with Mycobacterium tuberculosis but remain asymptomatic and non-contagious. However, without appropriate intervention,...
AI in Oncology Market Report 2024–2030: Growth Outlook, Key Drivers & Strategic Insights
The global AI in oncology market is entering a transformative phase as healthcare systems rapidly adopt artificial intelligence for cancer detection, diagnosis, treatment planning, and precision medicine. Valued at US$1.92 billion in 2023, the market expanded to US$2.45 billion in 2024 and is projected to surge at a robust CAGR of 29.4% from 2024 to 2030, ultimately reaching US$11.52 billion by 2030.
This...
Electronic Trial Master File (eTMF) Systems Market Outlook (2025–2030): Driving Digital Transformation in Clinical Research
The global Electronic Trial Master File (eTMF) Systems Market is undergoing rapid transformation as the clinical research ecosystem embraces digital-first workflows. Valued at US$1.21 billion in 2024, the market expanded to US$1.36 billion in 2025 and is projected to surge at a CAGR of 12.8% from 2025 to 2030, ultimately reaching US$2.49 billion by 2030. This substantial momentum reflects the industry’s...
Molecular Cytogenetics Market: Rising Demand for Precision Diagnostics Drives Strong 9.9% CAGR Growth to 2028
The Molecular Cytogenetics Market, valued at USD 3.1 billion in 2023, is projected to grow to USD 4.9 billion by 2028, advancing at a compelling CAGR of 9.9%. This strong trajectory is primarily driven by the rising incidence of cancer, increasing cases of genetic disorders, improved adoption of precision medicine, and rapid technological innovations in genomics and molecular diagnostics.
Download...
Immunotherapy Drugs Market: Strategic Imperatives and Growth Trajectories for the Next Decade
The New Frontier in Oncology and Beyond
Immunotherapy has moved beyond the realm of experimental medicine into the core of modern therapeutic strategies, particularly in oncology. As biopharmaceutical innovation accelerates and regulatory landscapes evolve, the immunotherapy drugs market stands at the forefront of a seismic transformation in healthcare delivery. Senior executives and industry leaders...
Custom Antibody Market: Driving Precision Medicine and Targeted Therapeutics (2024–2029)
The Custom Antibody Market is experiencing strong momentum as demand for tailored, high-specificity antibodies continues rising across drug discovery, diagnostics, and personalized medicine. According to the latest report by MarketsandMarkets™, the market—valued at $579 million in 2024—is projected to reach $901 million by 2029, growing at a robust CAGR of 9.2%.
Custom antibodies play a critical...
Electric Fuse Market Size to Grow $5.07 billion by 2030
According to a research report “Electric Fuse Market by Type (Power Fuse & Fuse Link, Distribution Cutouts, Cartridge & Plug Fuse), Current Type (AC, DC), Voltage (Low, Medium, High), End Users (Utilities, Transportation, Industrial, Residential, Commercial), Region – Global Forecast to 2030″, the electric fuse market is projected to reach USD 5.07 billion by 2030 from an...
Molecular Cytogenetics Market: Strong Growth Ahead (2024–2030)
The global Molecular Cytogenetics Market, valued at US$0.97 billion in 2024, is projected to grow at a CAGR of 7.1%, reaching US$1.02 billion in 2025 and an impressive US$1.43 billion by 2030.
What’s Driving the Market?
Rising incidence of cancer & genetic disorders
Growing adoption of advanced cytogenetic technologies
Increased use in clinical pathology testing
Expanding opportunities...